HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of vomiting after paediatric strabismus surgery: a systematic review using the numbers-needed-to-treat method.

Abstract
Randomized controlled studies were reviewed to assess the effectiveness and safety of antiemetics used for prophylaxis in paediatric strabismus surgery. Early and late vomiting (6 and 48 h after operation, respectively), and adverse effects were evaluated using the numbers-needed-to-treat method. In 27 reports with information on 2033 children, the mean incidence of early vomiting was 54% and of late vomiting 59%, without prophylaxis. Only three drugs were studied sufficiently for firm conclusions to be drawn. In the best documented regimen (droperidol 75 micrograms kg-1), four children have to be given the drug to prevent one vomiting; of the three others, one may vomit and two would not have vomited anyway; fewer than one child in 100 may have an extrapyramidal reaction and 16 may have minor adverse effects. Metoclopramide 0.15 and 0.25 mg kg-1 was significantly better than control only for early vomiting. Propofol had a high incidence of oculocardiac reflex without conferring any significant antiemetic effect: it should not be used. The benefits of prophylactic antiemetic therapy are not proven.
AuthorsM Tramèr, A Moore, H McQuay
JournalBritish journal of anaesthesia (Br J Anaesth) Vol. 75 Issue 5 Pg. 556-61 (Nov 1995) ISSN: 0007-0912 [Print] England
PMID7577280 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Chemical References
  • Antiemetics
  • Droperidol
  • Propofol
Topics
  • Antiemetics (therapeutic use)
  • Child
  • Droperidol (therapeutic use)
  • Humans
  • Postoperative Complications (prevention & control)
  • Propofol (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Strabismus (surgery)
  • Vomiting (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: